发明名称 Modulators of TNF-alpha signaling
摘要 The present invention provides compounds which are modulators of TNF-alpha signaling and methods of use thereof for treating a patient having a TNF-alpha mediated condition. The compounds can be represented by the following structural formulas:
申请公布号 US6969728(B2) 申请公布日期 2005.11.29
申请号 US20010852965 申请日期 2001.05.10
申请人 GENZYME CORPORATION 发明人 SNEDDON SCOTT F.;KANE JOHN L.;HIRTH BRADFORD H.;VINICK FRED;QIAO SHUANG;NAHILL SHARON R.;WILLIAMS JOHN M.;BIEMANN HANS-PETER
分类号 C07D295/14;A61K31/277;A61K31/405;A61K31/417;A61K31/4178;A61K31/4439;A61K31/444;A61K31/498;A61K31/506;A61K31/53;A61K31/5375;A61K31/5377;A61P1/04;A61P1/16;A61P3/10;A61P5/14;A61P7/00;A61P7/02;A61P9/10;A61P9/14;A61P19/02;A61P21/04;A61P25/14;A61P25/28;A61P25/32;A61P29/00;A61P31/00;A61P31/04;A61P31/10;A61P31/12;A61P31/18;A61P33/00;A61P35/00;A61P35/02;A61P37/02;A61P37/06;A61P43/00;C07C255/60;C07D233/54;C07D233/64;C07D401/12;C07D401/14;C07D403/12;C07D403/14;C07D405/12;C07D409/12;(IPC1-7):C07C233/00;A61K38/05;A61K38/06;A61K38/07 主分类号 C07D295/14
代理机构 代理人
主权项
地址